Sytematic Nationwide programs necessary to reduce CVD by 25 percent by 2025: Dr Salim Yusuf

Published On 2017-03-15 10:43 GMT   |   Update On 2017-03-15 10:43 GMT
Systematic nationwide programs for improved CVD treatment and control are essential, if India is to achieve a 25% or greater reduction in premature CVD mortality by year 2025 (the 25 × 25 goal).

This important observation has been made by world-renowned cardiologist and epidemiologist, Dr Salim Yusuf and co author Dr Philip Joseph in a paper published in the American Heart Journal. The article specifically talks about the epidemic of cardiovascular disease in South Asians and the time for Action, specifically on a policy front to overcome the current barriers to CVD prevention and management in South Asia.

The article titled The epidemic of cardiovascular disease in South Asians: Time for action looks at the prevalence and the risk factors associated with the cardiovascular diseases . Some of the important observations made in the article include

  • Evidence-based programs (both Central and State) in India and other low- and middle-income countries are essential to reduce CVD, but they need a comprehensive approach that tackles barriers at multiple levels in a health system.

  • In particular, there is a need to establish systems for Universal Health coverage to minimize the impact of catastrophic illnesses and out-of-pocket health care costs.

  • To achieve a 25% or greater reduction in premature CVD mortality by year 2025 (the 25 × 25 goal), systematic nationwide programs for improved CVD treatment and control are essential. Ideally, a CVD control program should start with a situation analysis, which documents the current burden of risk factors, CVD, and key treatments in representative population samples; the quality and density of health care facilities and trained personnel; access and affordability of essential services (eg, drugs, surgery, and devices); and the structure of health services. Success of government policies and programs to control CVD can be evaluated by repeat surveys to document their impact and will also provide information to appropriately modify the strategies.


You can read the full article by clicking on the following link

http://www.sciencedirect.com/science/article/pii/S0002870316302848

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News